FL
VRTX icon

Fort LP’s Vertex Pharmaceuticals VRTX Stock Holding History

Fort LP’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-485
Closed -$227K – 154
2024
Q2 		$227K Sell
485
-149
-24% -$64.7K 0.58% 114
2024
Q1 		$265K Sell
634
-116
-15% -$49K 0.67% 65
2023
Q4 		$305K Sell
750
-82
-10% -$30.3K 0.75% 28
2023
Q3 		$289K Sell
832
-37
-4% -$12.9K 0.8% 33
2023
Q2 		$306K Sell
869
-137
-14% -$46.2K 0.81% 28
2023
Q1 		$317K Sell
1,006
-501
-33% -$150K 0.82% 32
2022
Q4 		$435K Sell
1,507
-574
-28% -$175K 0.66% 45
2022
Q3 		$603K Sell
2,081
-777
-27% -$224K 0.75% 2
2022
Q2 		$805K Sell
2,858
-361
-11% -$96.6K 0.55% 60
2022
Q1 		$840K Sell
3,219
-69
-2% -$16.4K 0.32% 158
2021
Q4 		$722K Sell
3,288
-65
-2% -$12.6K 0.23% 190
2021
Q3 		$608K Sell
3,353
-1,668
-33% -$326K 0.2% 215
2021
Q2 		$1.01M Sell
5,021
-2,052
-29% -$429K 0.29% 179
2021
Q1 		$1.52M Buy
7,073
+585
+9% +$128K 0.43% 155
2020
Q4 		$1.53M Buy
6,488
+2,380
+58% +$546K 0.46% 130
2020
Q3 		$1.12M Buy
4,108
+2,006
+95% +$553K 0.47% 96
2020
Q2 		$610K Sell
2,102
-2,053
-49% -$557K 0.33% 152
2020
Q1 		$989K Buy
4,155
+2,466
+146% +$566K 0.22% 192
2019
Q4 		$370K Buy
+1,689
New +$342K 0.07% 262

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fort LP's VRTX Position: Q3 2024 in Review

Fort LP sold out of Vertex Pharmaceuticals (VRTX) in Q3 2024, closing a stake of 485 shares — an estimated $227K sold.

Fort LP first reported a position in VRTX in Q4 2019 and held it in 19 quarters. The position peaked at $1.53M in Q4 2020. 1,544 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

  • Fort LP reported no remaining Vertex Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Fort LP sold 485 Vertex Pharmaceuticals shares in Q3 2024, an estimated $227K.
  • Fort LP first reported a position in Vertex Pharmaceuticals in Q4 2019 and held it in 19 quarters.
  • Fort LP's Vertex Pharmaceuticals position peaked at $1.53M in Q4 2020.
  • 1,544 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on Fort LP's 13F filing for Q3 2024, filed 29 Oct 2024.